Receptor dysfunction in AD brains has been an active topic of research for decades, and most of the drugs approved for treating AD (NMDA antagonists, cholineste

Receptor dysfunction in AD brains has been an active topic of research for decades, and most of the drugs approved for treating AD (NMDA antagonists, cholinesterase inhibitors) modulate neuronal activity.